Clinical Trials for Melanoma
R3767-ONC-22122
A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolumab in Participants With Unresectable or Metastatic Melanoma. View details.
- Research
- Clinical Trials at UCBC
- Biliary Tract Cancer
- Bladder Cancer
- Brain & Spinal Cord Tumors
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gastric Tumors
- Head & Neck Cancer
- Leukemia
- Kidney Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Multiple Myeloma
- Neuroendocrine Tumors
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Sarcoma Tumors
- Solid Tumors
- Uterine Cancer
